GEN Exclusives

More »

GEN News Highlights

More »
Jun 22, 2010

Probactive and Vietnamese Organization to Combine Antibodies with Radioactive Compounds for Cancer

  • Probactive Biotech and Vietnamese organization Dalat Nuclear Research Institute are collaborating to develop cancer drugs that combine antitumor antibodies and radioactive compounds.

    Probactive Biotech says that it has combined medical-grade iodine-131 and yttrium-90 with antitumor antibodies, producing targeted anticancer activity.

    Parts of the R&D program will be completed at the Dalat Nuclear Research Institute. Clinical trials will be conducted in Vietnam under the regulatory guidelines of the Ministry of Health and also in compliance with FDA regulations.

     


Add a comment

  • You must be signed in to perform this action.
    Click here to Login or Register for free.
    You will be taken back to your selected item after Login/Registration.

Related content

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Should “Special K” Get Special Treatment?

In the near term, what is the best way to use ketamine in treating depression?